Literature DB >> 6942699

On metabolism and pharmacokinetics of an aromatic retinoid.

U Paravicini, K Stöckel, P J MacNamara, R Hänni, A Busslinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6942699     DOI： 10.1111/j.1749-6632.1981.tb12737.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  9 in total

1.  Dose-proportional absorption of etretinate after doses of 25, 50, 75, and 100 mg.

Authors:  R J Wills; L C Rodriguez; A H Lin; C Puccini; W A Colburn
Journal:  Pharm Res       Date:  1987-10       Impact factor: 4.200

2.  Decline of plasma concentrations of etretinate and its main metabolite after treatment.

Authors:  J Lauharanta; U Paravicini; L Kanerva; A Lassus
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

Review 3.  Pharmacokinetics and therapeutic efficacy of retinoids in skin diseases.

Authors:  F G Larsen; F Nielsen-Kudsk; P Jakobsen; K Weismann; K Kragballe
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  Hepatocanalicular injury associated with vitamin A derivative etretinate. An idiosyncratic hypersensitivity reaction.

Authors:  M R Khouri; S H Saul; A A Dlugosz; R D Soloway
Journal:  Dig Dis Sci       Date:  1987-10       Impact factor: 3.199

Review 5.  Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

6.  Solubilization of retinoids by bile salt/phospholipid aggregates.

Authors:  C Y Li; C L Zimmerman; T S Wiedmann
Journal:  Pharm Res       Date:  1996-06       Impact factor: 4.200

Review 7.  Clinical pharmacokinetics of the retinoids.

Authors:  R W Lucek; W A Colburn
Journal:  Clin Pharmacokinet       Date:  1985 Jan-Feb       Impact factor: 6.447

8.  Pharmacokinetics of acitretin and its 13-cis metabolite in patients on haemodialysis.

Authors:  A E Stuck; C J Brindley; A Busslinger; F J Frey
Journal:  Br J Clin Pharmacol       Date:  1989-03       Impact factor: 4.335

9.  Acitretin : A Review of its Pharmacology and Therapeutic Use.

Authors:  Tania Pilkington; Rex N Brogden
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.